What is the price target for HSTM stock?
11 analysts have analysed HSTM and the average price target is 21.42 USD. This implies a price increase of 7.58% is expected in the next year compared to the current price of 19.91.
HEALTHSTREAM INC (HSTM) Forecast, Price Target & Analyst Ratings
NASDAQ:HSTM • US42222N1037
Current stock price
19.91 USD
-0.42 (-2.07%)
At close:
20.06 USD
+0.15 (+0.75%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHSTREAM INC (HSTM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.17
- Revenue Estimate
- 81.268M
Price Target Details & History
Consensus Price Target and Range
Mean target
$21.42
Upside
+ 7.58%
From current price of $19.91 to mean target of $21.42, Based on 11 analyst forecasts
Low
$21.21
Median
$21.42
High
$22.05
Price Target Revisions
1 Month
-35.38%
3 Months
-38.24%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for HSTM. The average price target is 21.42 USD. This implies a price increase of 7.58% is expected in the next year compared to the current price of 19.91.
The average price target has been revised downward by 38.24% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.18%
HSTM was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about HSTM.
In the previous month the buy percentage consensus was at a similar level.
HSTM was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-07 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-05-15 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-26 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-10-23 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-23 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-07-24 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-12-06 | JMP Securities | Initiate | Market Perform |
| 2023-02-22 | Canaccord Genuity | Maintains | Hold |
| 2021-04-28 | Canaccord Genuity | Maintains | Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.17
- Revenue Estimate
- 81.268M
- Revenue Q2Q
- 10.59%
- EPS Q2Q
- 18.39%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
0.38%
Revenue (3 Months)
3.49%
EPS (1 Month)
-2.99%
EPS (3 Months)
1.56%
Next Earnings Summary
HSTM is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is 0.17 USD and the consensus revenue estimate is 81.27M USD.
The next earnings revenue estimate has been revised upward by 3.49% in the past 3 months.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 279.063M 4.60% | 291.646M 4.51% | 304.064M 4.26% | 332.81M 9.45% | 349.85M 5.12% | 346.74M -0.89% | 365.81M 5.50% | 387.76M 6.00% | 409.09M 5.50% | 429.54M 5.00% | |
| EBITDA YoY % growth | 57.095M 13.40% | 62.53M 9.52% | 63.714M 1.89% | 77.906M 22.27% | 83.447M 7.11% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 16.019M 29.19% | 21.287M 32.89% | 20.236M -4.94% | 27.053M 33.69% | 30.379M 12.29% | 31.207M 2.73% | 34.752M 11.36% | 38.776M 11.58% | 42.954M 10.77% | 47.249M 10.00% | |
| Operating Margin | 5.74% | 7.30% | 6.66% | 8.13% | 8.68% | 9.00% | 9.50% | 10.00% | 10.50% | 11.00% | |
| EPS YoY % growth | 0.50 28.21% | 0.66 32.00% | 0.70 6.06% | 0.77 9.29% | 0.88 14.67% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.17 18.39% | 0.18 -0.83% | 0.19 -3.10% | 0.21 17.58% | 0.22 32.31% | 0.22 25.71% | 0.22 15.79% | 0.23 8.43% |
| Revenue Q2Q % growth | 81.268M 10.59% | 82.305M 10.63% | 83.717M 9.47% | 85.515M 7.29% | 85.69M 5.44% | 86.522M 5.12% | 87.73M 4.79% | 89.255M 4.37% |
| EBITDA Q2Q % growth | 18.356M 21.30% | 18.846M -31.49% | 19.429M -51.44% | 20.218M -55.93% | 20.201M 10.05% | 20.441M 8.46% | 20.808M 7.10% | 21.094M 4.33% |
| EBIT Q2Q % growth | 6.097M 39.26% | 6.432M 9.28% | 6.926M -8.47% | 7.598M 216.06% | 7.854M 28.82% | 8.16M 26.87% | 8.364M 20.76% | 8.262M 8.74% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.19%
Revenue Next 5 Year
4.81%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
HEALTHSTREAM INC / HSTM Forecast FAQ
What is the next earnings date for HSTM stock?
HEALTHSTREAM INC (HSTM) will report earnings on 2026-04-27.
What are the consensus estimates for HEALTHSTREAM INC (HSTM) next earnings?
The consensus EPS estimate for the next earnings of HEALTHSTREAM INC (HSTM) is 0.17 USD and the consensus revenue estimate is 81.27M USD.
How many analysts have analysed HEALTHSTREAM INC (HSTM)?
The number of analysts covering HEALTHSTREAM INC (HSTM) is 11.